Lithographically Defined Three Dimensional Graphene Structures. | |
MedLine Citation:
|
PMID: 22404283 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
A simple and facile method to fabricate 3D graphene architectures is presented. Pyrolyzed photoresist films (PPF) can easily be patterned into a variety of 2D and 3D structures. We demonstrate how pre-structured PPF can be chemically converted into hollow, interconnected 3D multilayered graphene structures having pore sizes around 500 nm. Electrodes formed from these structures exhibit excellent electrochemical properties including high surface area, and mass transport profiles due to a unique combination of 3D pore structure and the intrinsic advantages of electron transport in graphene, which makes this material a promising candidate for micro-battery and sensing applications. |
Authors:
|
Xiaoyin Xiao; Thomas E Beechem; Michael Todd Brumbach; Timothy N Lambert; Danae J Davis; Joseph Michael; Cody M Washburn; Joseph Wang; Susan M Brozik; David R Wheeler; David Bruce Burckel; Ronen Polsky |
Related Documents
:
|
8947573 - Nmr solution structure of cu(i) rusticyanin from thiobacillus ferrooxidans: structural ... 9783253 - Dynamic contact maps of protein structures. 17406563 - Mass spectrometric identification of n-linked glycopeptides using lectin-mediated affin... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-3-9 |
Journal Detail:
|
Title: ACS nano Volume: - ISSN: 1936-086X ISO Abbreviation: - Publication Date: 2012 Mar |
Date Detail:
|
Created Date: 2012-3-12 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101313589 Medline TA: ACS Nano Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
MeSH Terms | |
Descriptor/Qualifier:
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cerebral vascular effects of hypovolemia and dopamine infusions: a study in newborn piglets.
Next Document: Symmetrical analysis of risk-benefit.